These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 223992)

  • 1. Macrophage-dependent, NK-cell-independent "natural" surveillance of tumors in syngeneic mice.
    Chow DA; Greene MI; Greenberg AH
    Int J Cancer; 1979 Jun; 23(6):788-97. PubMed ID: 223992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine natural anti-tumor antibodies. II. The contribution of natural antibodies to tumor surveillance.
    Chow DA; Wolosin LB; Greenberg AH
    Int J Cancer; 1981; 27(4):459-69. PubMed ID: 6792086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative studies of natural immunity to solid tumours in rats. NK activity in animals with primary or transplanted spontaneous tumours.
    Flannery GR; Brooks CG
    Int J Cancer; 1981 Dec; 28(6):747-55. PubMed ID: 7333706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of poly I:C-activated peritoneal cells on the take of transplantable murine tumours.
    Minárovits J; Karczag E; Földes I
    Acta Microbiol Hung; 1987; 34(3-4):197-205. PubMed ID: 3129897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
    Kumar V; Luevano E; Bennett M
    J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid resistance against a natural killer (NK) cell-resistant lymphoma (YWA) is mediated by a T cell-dependent mechanism.
    Grönberg A; Klein GO; Kärre K; Kiessling R; Klein G
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):183-90. PubMed ID: 7201394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in selectivity of tumor cell cytolysis by murine macrophages, macrophage-like cell lines and NK cells.
    Wiltrout RH; Brunda MJ; Holden HT
    Int J Cancer; 1982 Sep; 30(3):335-42. PubMed ID: 6813271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ly-6C+ natural T (NT) cells mediate immune surveillance against NK-sensitive and NK-resistant transplantable tumours in certain strains of mice.
    Martiniello R; Burton RC; Smart YC
    Int J Cancer; 1996 May; 66(4):532-7. PubMed ID: 8635870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells may be the only cells in normal mouse lymphoid cell populations endowed with cytolytic ability for antibody-coated tumour target cells.
    Ojo E; Wigzell H
    Scand J Immunol; 1978 Apr; 7(4):297-306. PubMed ID: 418499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage cytotoxicity in the mouse immune response against a skin allograft.
    Dimitriu A; Dy M; Thomson N; Hamburger J
    J Immunol; 1975 Jan; 114(1 Pt 1):195-9. PubMed ID: 122985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity.
    Puccetti P; Santoni A; Riccardi C; Holden HT; Herberman RB
    Int J Cancer; 1979 Dec; 24(6):819-25. PubMed ID: 232496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physico-chemical characteristics of tumour cells susceptible to lysis by natural killer (NK) cells.
    Becker S; Stendahl O; Magnusson KE
    Immunol Commun; 1979; 8(1):73-83. PubMed ID: 105988
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of lymphoma grafts on natural killer cell activity in AKR and C57BL/6 mice.
    Vaillier D; Labat V; Legrand E; Duplan JF
    Nat Immun Cell Growth Regul; 1986; 5(1):41-9. PubMed ID: 3084955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high frequency of cytotoxic precursor cells for a syngeneic tumour.
    Warren HS; Lafferty KJ
    Scand J Immunol; 1979; 10(4):349-52. PubMed ID: 119310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength.
    Fiszer-Maliszewska L; Den Otter W; Mordarski M
    Cancer Immunol Immunother; 1999 Feb; 47(6):307-14. PubMed ID: 10203060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-adaptive rejection of small tumour inocula as a model of immune surveillance.
    Greenberg AH; Greene M
    Nature; 1976 Nov; 264(5584):356-9. PubMed ID: 826828
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of the growth of lymphoid tumours in syngeneic athymic (nude) mice.
    Warner NL; Woodruff MF; Burton RC
    Int J Cancer; 1977 Jul; 20(1):146-55. PubMed ID: 903182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of augmentation of natural killer cell activity by syngeneic tumor cells: role of macrophage-derived factor in NK boosting.
    Kawase I; Urdal DL; Newman W; Henney CS
    Int J Cancer; 1983 Mar; 31(3):365-72. PubMed ID: 6402456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells.
    Chow DA; Wolosin LB; Greenberg AH
    J Natl Cancer Inst; 1981 Aug; 67(2):445-53. PubMed ID: 6943381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of tumor progression from threshold tumor inocula: evidence for natural resistance.
    Brown GW; Chow DA
    Int J Cancer; 1985 Mar; 35(3):385-93. PubMed ID: 3972473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.